Therapeutic uses of recombinant complement protein inhibitors

by Kalli, Kimberly R., Hsu, Peihong, Fearon, Douglas T.
Published in Springer Semin Immunopathol (1994)

The Immune System in the Pathogenesis of Ovarian Cancer

by Charbonneau, Bridget, Goode, Ellen L., Kalli, Kimberly R., Knutson, Keith L., DeRycke, Melissa S.
Published 2013

Immunity and immune suppression in human ovarian cancer

by Preston, Claudia C, Goode, Ellen L, Hartmann, Lynn C, Kalli, Kimberly R, Knutson, Keith L
Published 2011

Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer

by White, Kristin L., Rider, David N., Kalli, Kimberly R., Knutson, Keith L., Jarvik, Gail P., Goode, Ellen L.
Published 2011

Toward understanding the genetics of regulatory T cells in ovarian cancer

by DeRycke, Melissa S, Charbonneau, Bridget, Preston, Claudia C, Kalli, Kimberly R, Knutson, Keith L, Rider, David N, Goode, Ellen L
Published 2013

Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer

by Chien, Jeremy, Neums, Lisa, Powell, Alexis F. L. A., Torres, Michelle, Kalli, Kimberly R., Multinu, Francesco, Shridhar, Viji, Mariani, Andrea
Published in Front Oncol (2018)

Folate receptor alpha as a tumor target in epithelial ovarian cancer

by Kalli, Kimberly R., Oberg, Ann L., Keeney, Gary L., Christianson, Teresa J.H., Low, Philip S., Knutson, Keith L., Hartmann, Lynn C.
Published 2008

Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors Following Combination Therapy with Vaccine and Anti-PD-1 Antibody

by Karyampudi, Lavakumar, Lamichhane, Purushottam, Scheid, Adam D, Kalli, Kimberly R., Shreeder, Barath, Krempski, James W., Behrens, Marshall D, Knutson, Keith L.
Published in Cancer Res (2014)

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival

by Jatoi, Aminah, Foster, Nathan R., Kalli, Kimberly R., Vierkant, Robert A., Zhang, Zhiying, Larson, Melissa C., Fridley, Brooke, Goode, Ellen L.
Published in BMC Cancer (2015)

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands

by He, Wei, Kularatne, Sumith A., Kalli, Kimberly R., Prendergast, Franklyn G., Amato, Robert J., Klee, George G., Hartmann, Lynn C., Low, Philip S.
Published 2008

Plasma immune analytes in patients with epithelial ovarian cancer

by Block, Matthew S., Maurer, Matthew J., Goergen, Krista, Kalli, Kimberly R., Erskine, Courtney L., Behrens, Marshall D., Oberg, Ann L., Knutson, Keith L.
Published in Cytokine (2015)

Tumor infiltrating PD-1(+) dendritic cells mediate immune suppression in ovarian cancer

by Krempski, James, Karyampudi, Lavakumar, Behrens, Marshall D., Erskine, Courtney L., Hartmann, Lynn, Dong, Haidong, Goode, Ellen L., Kalli, Kimberly R., Knutson, Keith L.
Published 2011

Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer

by Carlson, Aaron M., Maurer, Matthew J., Goergen, Krista M., Kalli, Kimberly R., Erskine, Courtney L., Behrens, Marshall D., Knutson, Keith L., Block, Matthew S.
Published 2013

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth

by Becker, Marc A., Farzan, Thahir, Harrington, Sean C., Krempski, James W., Weroha, S. John, Hou, Xiaonan, Kalli, Kimberly R., Wong, Tai W., Haluska, Paul
Published 2013

Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer

by Winham, Stacey J., Armasu, Sebastian M., Cicek, Mine S., Larson, Melissa C., Cunningham, Julie M., Kalli, Kimberly R., Fridley, Brooke L., Goode, Ellen L.
Published 2014

The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

by Preston, Claudia C., Maurer, Matthew J., Oberg, Ann L., Visscher, Daniel W., Kalli, Kimberly R., Hartmann, Lynn C., Goode, Ellen L., Knutson, Keith L.
Published 2013

The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins

by Li, Zheng, Block, Matthew S., Vierkant, Robert A., Fogarty, Zachary C., Winham, Stacey J., Visscher, Daniel W., Kalli, Kimberly R., Wang, Chen, Goode, Ellen L.
Published in Tumour Biol (2016)

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()

by Butler, Kristina A., Hou, Xiaonan, Becker, Marc A., Zanfagnin, Valentina, Enderica-Gonzalez, Sergio, Visscher, Daniel, Kalli, Kimberly R., Tienchaianada, Piyawan, Haluska, Paul, Weroha, S. John
Published in Neoplasia (2017)

An Integrative Approach to Assess X-Chromosome Inactivation Using Allele-Specific Expression with Applications to Epithelial Ovarian Cancer

by Larson, Nicholas B., Fogarty, Zachary C., Larson, Melissa C., Kalli, Kimberly R., Lawrenson, Kate, Gayther, Simon, Fridley, Brooke L., Goode, Ellen L., Winham, Stacey J.
Published in Genet Epidemiol (2017)

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

by Behrens, Marshall D., Wagner, Wolfgang M., Krco, Christopher J., Erskine, Courtney L., Kalli, Kimberly R., Krempski, James, Gad, Ekram A., Disis, Mary L., Knutson, Keith L.
Published 2008